logo-large
  • Browse Categories

Publications by authors named "Mitchell D Nambu"

Claim this Profile
4
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors.
Kevin K-C Liu, Shubha Bagrodia, Simon Bailey, Hengmiao Cheng, Hui Chen, Mitchell D Nambu

Bioorg Med Chem Lett· October 2010


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.
Helen Y Zou, Qiuhua Li, Joseph H Lee, Maria E Arango, Scott R McDonnell, Mitchell D Nambu

Cancer Res· May 2007


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: